Reasons To Limit Inventor Testimony In Hatch-Waxman Cases
Inventor testimony inevitably forms a part of every generic drug company's case in a Paragraph IV obviousness challenge under the Hatch-Waxman Act.[1] This is odd because the generic defendant in its...To view the full article, register now.
Already a subscriber? Click here to view full article